Diagnosis

At Alma pharmaceutical, our sustainability strategy is focused around three core areas; our people, our planet, and the places in which we operate, all underpinned by a clear ethical framework

Book Now Pharmaceutical Method Development and Validation
Diagnosis

Release testing covers a variety of tests to address the purity, concentration, consistency, identity and safety of the product. Typical testing would comprise of appearance, assay and impurities, dissolution and microbial testing. It is essential that the methodology involved is robust, to ensure the products’ safety and integrity, and reproducible, in order to minimise out-of-specification or out-of-trend repeats .

Book Now Drug product, medical devices and biologics
Diagnosis

Specialising in solid oral dosage forms, Almac has the technical experience and knowledge to develop robust formulations and manufacturing processes suitable for late phase clinical trials, registration and ongoing commercial supply.

Book Now Late Phase Pharmaceutical Drug Product Development
Doctor

Solid State Services

Enabling Salt Screen

If your drug candidate is at risk of failure due to poor oral bioavailability, handling issues or instability, or simply you want to develop a new dosage form, a salt (or cocrystal) form has the potential to dramatically improve the drug properties. An enabling salt screen has a quick turnaround and can be performed on less than 100mg. Almac has a proven track record in getting troublesome discovery candidates into the clinical phase using this method.

Polymorph Screening

Polymorph screening is designed to reduce the risks of drug development by finding the most stable form of the API and to define the form for clinical development and GMP manufacture. Our screening services are directed by highly trained chemists and analysts performing a scientific investigation tailored to your API properties, development phase and budget, rather than generic protocols using robotics.

Salt and Cocrystal Screening

The selection of an appropriate salt provides an opportunity to modify the API’s physicochemical properties and resultant biological characteristics. However, the salt form selected will influence a range of other properties. It should also be noted that screening for developable salt forms could strengthen the intellectual property of the API. A salt or cocrystal can also enable you to go over the next hurdle in the pharmaceutical drug development process, whether this is to move onto the initial toxicity studies or to go into clinical drug development.

Amorphous Solids

Amorphous drug substances can exhibit enhanced solubility over a crystalline form. However, the amorphous solid may be unstable to recrystallisation during the shelf life of a product unless it is stabilised as an amorphous solid dispersion. We can rapidly identify the most suitable polymers at the correct concentration for early drug formulation development. Prototypes are generated by solvent casting, co-melting, freeze drying or spray drying, fully characterised and their stability assessed. The scope will be tailored to your needs, development phase and budget.

Meet Our Specialist

This strategy is set, driven and overseen by our Board of Directors and Senior Executive team to ensure it plays an integral part in all company operations. Each day, the tactical aspects of this strategy are demonstrated, upheld and nurtured by our diligent management and operational teams.

With access to

24 Hour

Emergency

Assistance

The Alma pharmaceutical company has been built upon a foundation of integrity and respect. We conduct our business in a fair, open and transparent manner and operate to the highest ethical standards in all jurisdictions in which we do business. Our commitment to ethical business is not just good policy; it is fundamental to the success of our organisation and to our mission to advance human health.

Emergency

Medical Care 24/7

With access to 24 hour emergency assistance, It’s so important you can continue to help others.

Quick Amenities in Alma Pharmaceutical

At Alma, our sustainability strategy is focused around three core areas; our people, our planet, and the places in which we operate, all underpinned by a clear ethical framework

 

This strategy is set, driven and overseen by our Board of Directors and Senior Executive team to ensure it plays an integral part in all company operations. Each day, the tactical aspects of this strategy are demonstrated, upheld and nurtured by our diligent management and operational teams.

Gallery of Alma Pharmaceutical Company

Online Medicine

Online Medicine

Online Medicine

Online Medicine

Online Medicine

Online Medicine

Service Recipient Says

Oxmox advised her not to do so, because there were thousands of bad Commas, wild Question Marks and devious.

Kolis Muller NY Citizen

Oxmox advised her not to do so, because there were thousands of bad Commas, wild Question Marks and devious.

Kolis Muller NY Citizen

Oxmox advised her not to do so, because there were thousands of bad Commas, wild Question Marks and devious.

Kolis Muller NY Citizen

Oxmox advised her not to do so, because there were thousands of bad Commas, wild Question Marks and devious.

Kolis Muller NY Citizen

News & Blog

This strategy is set, driven and overseen by our Board of Directors and Senior Executive team to ensure it plays an integral part in all company operations. Each day, the tactical aspects of this strategy are demonstrated, upheld and nurtured by our diligent management and operational teams.